Some studies have described a correlation between detectable DOG1 immunostaining and poor prognosis or tumor aggressivity among various cancers of the prostate, breast, ovary, esophagus, stomach, pancreas, head and neck, liver and others [9,10,11,13,14,16,17,18,19,20,21,22,23,24]. Here, ANO1 is linked to neoplasm.